PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA Conference

Grommes, Christian, Mehta, Minesh, Miller, Alexandra et al. (2020). PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA . NEURO-ONCOLOGY, 22 36-36.

cited authors

  • Grommes, Christian; Mehta, Minesh; Miller, Alexandra; Daras, Mariza; Piotrowski, Anna; Boire, Adrienne; Butler, Brittany; Stone, Jacqueline; Pentsova, Elena; Kotecha, Rupesh; Morrison, Tara; Odia, Yazmin; Mellinghoff, Ingo; Beal, Kathryn

authors

date/time interval

  • November 19, 2020 -

publication date

  • November 1, 2020

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • ELECTR NETWORK

Conference

  • 25th Virtual Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 36

end page

  • 36

volume

  • 22